Therapeutic activity of sarpogrelate and dopamine D(2) receptor agonists on cardiovascular and renal systems in rats with alloxan-induced diabetes

BACKGROUND: Dopamine D(2) receptor agonists, bromocriptine and cabergoline, are notable medications in the treatment of Parkinsonism, hyperprolactinemia, and hyperglycemia. An affiliation was found between the initiation of myocardial injury ailment and long term treatment with dopamine D(2) agonist...

Descripción completa

Detalles Bibliográficos
Autores principales: Fouad Shalaby, Mohammed Ahmed, Abd El Latif, Hekma A., El Yamani, Mohamed, Galal, May Ahmed, Kamal, Sherifa, Sindi, Ikhlas, Masaood, Raneem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547108/
https://www.ncbi.nlm.nih.gov/pubmed/34702339
http://dx.doi.org/10.1186/s40360-021-00526-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547108/
https://www.ncbi.nlm.nih.gov/pubmed/34702339
http://dx.doi.org/10.1186/s40360-021-00526-6

Ejemplares similares